Davidson C, McLachlan M S, Burkinshaw L, Morgan D B
Lancet. 1976 Nov 13;2(7994):1044-7. doi: 10.1016/s0140-6736(76)90965-x.
Plasma and total body potassium have been measured in 151 patients with chronic heart-disease, 83 of whom were taking diuretics and potassium supplements. After allowance for age and body-size, the deficit in total body-potassium was only 3-5% (100-150 mmol) in the diuretic group. 13 of the 83 patients taking diuretic had hypokalaemia (less than 3-5 mmol/1) but the potassium deficit was no greater than in the patients with normal plasma-potassium. There was no relation between the dose of potassium supplements and either the plasma-potassium or the total body-potasium. It is suggested that potassium depletion is not a major problem in patients with heart-failure treated with diuretics. The dose of potassium supplements should therefore be determined entirely by the plasma-potassium.
对151例慢性心脏病患者测定了血浆钾和全身钾含量,其中83例正在服用利尿剂和钾补充剂。在考虑年龄和体型因素后,利尿剂组全身钾缺乏仅为3 - 5%(100 - 150毫摩尔)。83例服用利尿剂的患者中有13例出现低钾血症(低于3.5毫摩尔/升),但其钾缺乏程度并不比血浆钾正常的患者更严重。钾补充剂的剂量与血浆钾或全身钾均无关联。提示在用利尿剂治疗的心力衰竭患者中,钾缺乏并非主要问题。因此,钾补充剂的剂量应完全由血浆钾水平决定。